Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference46 articles.
1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.
2. FDA (2018). Preventable Adverse Drug Reactions: A Focus on Drug Interactions. https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse-drug-reactions-focus-drug-interactions. Accessed 22 August 2022.
3. Huybrechts KF, Desai RJ, Park M, Gagne JJ, Najafzadeh M, Avorn J. The potential return on public investment in detecting adverse drug effects. Med Care. 2017;55:545–51.
4. Downing NS, Shah ND, Aminawung JA, Pease AM, Zeitoun JD, Krumholz HM, et al. Postmarket safety events among novel therapeutics approved by the US food and drug administration between 2001 and 2010. JAMA. 2017;317:1854–63.
5. Rogers AS. Adverse drug events: identification and attribution. Drug Intell Clin Pharm. 1987;21:915–20.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献